CHARLESTON, S.C., Sept. 22, 2010 (GLOBE NEWSWIRE) -- Revolutions Medical ("Revolutions Medical" or the "Company) (OTCBB:RMCP) will host a reception and present to distributors and healthcare professionals at the Dusseldorf Intercontinental Hotel located on Konigsallee 59 on Wednesday November 17th and Thursday the 18th from 7:00 - 10:00 PM. Attendees can check out samples of the new RevVac Safety Syringe. The Company also plans to interview and engage new prospective distributors from around the world.
"We look forward to our reception and introducing our syringe to new potential distributors, as well as working towards solidifying our ongoing global distribution relationships that include individual countries, governments and militaries," states Ron Wheet, CEO, Revolutions Medical.
MEDICA is the world's largest forum for those involved in the healthcare industry. More than 138,000 visitors attend from more than 100 countries. MEDICA features 4,300 exhibitors with more than 450 from the USA and Canada, making MEDICA the strongest medical industry trade fair outside the North American Continent for US and Canadian Companies.
For additional information on the Company, and to RSVP for the reception, please visit our website at
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. The Company also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.
For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com
Investor Resource Center
CEO Ron Wheet Audio Interview:
RevVac Safety Syringe Demonstration Video:
RevColor MRI Video:
To be added to the Revolutions Medical investor email list, please email Skey@revolutionsmedical.com with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook -- visit http://www.Facebook.com/Revmed
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
CONTACT: Revolutions Medical Corporation Investor Relations: Scott Key 843-518-0437 Skey@revolutionsmedical.com